These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 2464720)

  • 41. Zoledronic acid is unable to induce apoptosis, but slows tumor growth and prolongs survival for non-small-cell lung cancers.
    Li YY; Chang JW; Chou WC; Liaw CC; Wang HM; Huang JS; Wang CH; Yeh KY
    Lung Cancer; 2008 Feb; 59(2):180-91. PubMed ID: 17900752
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparison of the response of synchronized HeLa cells to talisomycin and bleomycin.
    Mirabelli CK; Crooke ST
    Cancer Chemother Pharmacol; 1981; 5(4):251-6. PubMed ID: 6167377
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effects of aclacinomycin on cell survival and cell cycle progression of cultured mammalian cells.
    Traganos F; Staiano-Coico L; Darzynkiewicz Z; Melamed MR
    Cancer Res; 1981 Jul; 41(7):2728-37. PubMed ID: 6166368
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A new method to discriminate G1, S, G2, M, and G1 postmitotic cells.
    Giaretti W; Nüsse M; Bruno S; Di Vinci A; Geido E
    Exp Cell Res; 1989 May; 182(1):290-5. PubMed ID: 2714405
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Chromosome aberrations in normal human fibroblasts analyzed in G0/G1 and G2/M phases after exposure in G0 to radiation with different linear energy transfer (LET).
    Liu C; Kawata T; Furusawa Y; Zhou G; Inoue K; Fukada J; Kota R; George K; Cucinotta F; Okayasu R
    Mutat Res; 2013 Aug; 756(1-2):101-7. PubMed ID: 23688614
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cell cycle-dependent cytotoxicity, G2/M phase arrest, and disruption of p34cdc2/cyclin B1 activity induced by doxorubicin in synchronized P388 cells.
    Ling YH; el-Naggar AK; Priebe W; Perez-Soler R
    Mol Pharmacol; 1996 May; 49(5):832-41. PubMed ID: 8622633
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Retinoic acid-mediated growth inhibition of small cell lung cancer cells is associated with reduced myc and increased p27Kip1 expression.
    Weber E; Ravi RK; Knudsen ES; Williams JR; Dillehay LE; Nelkin BD; Kalemkerian GP; Feramisco JR; Mabry M
    Int J Cancer; 1999 Mar; 80(6):935-43. PubMed ID: 10074929
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Selective inhibition of bleomycin-induced G2 cell cycle checkpoint by simaomicin alpha.
    Arai M; Sato H; Kobayashi H; Suganuma M; Kawabe T; Tomoda H; Omura S
    Biochem Biophys Res Commun; 2004 May; 317(3):817-22. PubMed ID: 15081413
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Radiation-induced apoptosis in human non-small-cell lung cancer cell lines is secondary to cell-cycle progression beyond the G2-phase checkpoint.
    Stuschke M; Sak A; Wurm R; Sinn B; Wolf G; Stüben G; Budach V
    Int J Radiat Biol; 2002 Sep; 78(9):807-19. PubMed ID: 12428922
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Maitotoxin, a calcium channel activator, inhibits cell cycle progression through the G1/S and G2/M transitions and prevents CDC2 kinase activation in GH4C1 cells.
    Van Dolah FM; Ramsdell JS
    J Cell Physiol; 1996 Jan; 166(1):49-56. PubMed ID: 8557775
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Retinoblastoma tumor suppressor gene expression determines the response to sequential flavopiridol and doxorubicin treatment in small-cell lung carcinoma.
    Budak-Alpdogan T; Chen B; Warrier A; Medina DJ; Moore D; Bertino JR
    Clin Cancer Res; 2009 Feb; 15(4):1232-40. PubMed ID: 19174488
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Study of the effect of antitumor agents on cell cycle traverse by flow cytometry].
    Mitomo Y; Takamoto S
    Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 2-1):1019-25. PubMed ID: 3389824
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cell-cycle progression and response of germ cell tumors to cisplatin in vitro.
    Mueller S; Schittenhelm M; Honecker F; Malenke E; Lauber K; Wesselborg S; Hartmann JT; Bokemeyer C; Mayer F
    Int J Oncol; 2006 Aug; 29(2):471-9. PubMed ID: 16820891
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Alteration of cell cycle progression in human leukemia cell line (KOPM-28) induced by 12-o-tetradecanoylphorbol-13-acetate.
    Tsuda H; Sakaguchi M; Kawakita M; Nakazawa S; Mori T; Takatsuki K
    Int J Cell Cloning; 1988 May; 6(3):209-20. PubMed ID: 3397593
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cytostatic synergism between bromodeoxyuridine, bleomycin, cisplatin and chlorambucil demonstrated by a sensitive cell kinetic assay.
    Poot M; Schuster A; Hoehn H
    Biochem Pharmacol; 1991 Jun; 41(12):1903-9. PubMed ID: 1710121
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Apoptosis may be either suppressed or enhanced with strategic combinations of antineoplastic drugs or anti-IgM.
    Lin CK; Nguyen TT; Morgan TL; Mei RL; Kaptein JS; Kalunta CI; Yen CF; Park E; Zou HY; Lad PM
    Exp Cell Res; 1998 Oct; 244(1):1-13. PubMed ID: 9770343
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cell cycle dependence of cytotoxicity and clastogenicity induced by treatment of synchronized human diploid fibroblasts with sodium fluoride.
    Hayashi N; Tsutsui T
    Mutat Res; 1993 Dec; 290(2):293-302. PubMed ID: 7694121
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Bis(2-chloroethyl)sulfide (BCES) disturbs the progression of rat keratinocytes through the cell cycle.
    Lin PP; Bernstein IA; Vaughan FL
    Toxicol Lett; 1996 Jan; 84(1):23-32. PubMed ID: 8597174
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cell kinetic changes in cultured tumor cells after treatment with radiation and chemotherapy.
    Murata T; Akagi K; Uda M; Kimura H; Nasu R; Tanaka Y
    Int J Oncol; 1998 Jan; 12(1):171-4. PubMed ID: 9454901
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Use of 111In-bleomycin for combining radiotherapy and chemotherapy on glioma-bearing mice.
    Hou DY; Hoch H; Johnston GS; Tsou KC; Farkas RJ; Miller EE
    J Surg Oncol; 1985 Jun; 29(2):71-7. PubMed ID: 2417054
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.